Follow-up of the monitored levels of preservative sensitivity in Europe. Overview of the years 2001-2008-Reference-Cited by-同舟云学术

Follow-up of the monitored levels of preservative sensitivity in Europe. Overview of the years 2001-2008

Published:2012-10-08 Issue:5 Volume:67 Page:312-314
ISSN:0105-1873
Container-title:Contact Dermatitis
language:en
Short-container-title:

Author:

Svedman Cecilia,Andersen Klaus E.,Brandão F. M.,Bruynzeel Derk P.,Diepgen Thomas L.,Frosch Peter J.,Rustemeyer Thomas,Giménez-Arnau Ana,Gonçalo Margarida,Goossens An,Johansen Jeanne Duus,Lahti Arto,Menné Torkil,Seidenari Stefania,Tosti Antonella,Wahlberg Jan E.,White Ian R.,Wilkinson John D.,Mowitz Martin,Bruze Magnus

Publisher

Wiley

Subject

Dermatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0536.2012.02140.x/fullpdf

Reference19 articles.

1. Monitoring levels of preservative sensitivity in Europe.;Wilkinson;Contact Dermatitis,2002

2. Temporal trends of preservative allergy in Denmark (1985-2008).;Thyssen;Contact Dermatitis,2010

3. Contact allergy to preservatives. Analysis of IVDK data 1996-2009.;Schnuch;Br J Dermatol,2011

4. Low sensitization rate but good clinical relevance of preservatives in Turkey: evaluation of 1256 patients over 10 years (1996-2006).;Ozkaya;J Dermatol,2011

5. Globalisation and allergy.;Castelain;Eur J Dermatol,2011

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unexpected Early-Type Hypersensitivity Reactions Induced by Rectal Enema in Two Pediatric Cases and Review of the Literature;ASTHMA ALLERGY IMMUN;2024

2. Contact Dermatitis Due to Hair Care Products: A Comprehensive Review;Cosmetics;2024-05-09

3. Analysis of preservatives and fragrances in topical medical devices: The need for more stringent regulation;Contact Dermatitis;2024-03-12

4. Health safety of parabens evaluated by selected in vitro methods;Regulatory Toxicology and Pharmacology;2023-01

5. Decision making in next generation risk assessment for skin allergy: Using historical clinical experience to benchmark risk;Regulatory Toxicology and Pharmacology;2022-10